Stock MOR2 MORPHOSYS AG
Add to a list
To use this feature you must be a member
Log inSign up

Highlights MorphoSys AG Deutsche Boerse AG

Equities

MOR2

US6177602025

Market Closed - Deutsche Boerse AG
Other stock markets
 08:05:13 25/06/2024 BST 		5-day change 1st Jan Change
16.5 EUR 0.00% Intraday chart for MorphoSys AG -0.60% +96.43%
06-24 INDEX-MONITOR: Tui, Rational and Traton in the MDax - Douglas moves up to the SDax DP
06-24 MorphoSys AG(XTRA:MOR) dropped from Germany TECDAX (Total Return) Index CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15
DP
Novartis: towards the filing of a buyout offer for MorphoSys
CF
MorphoSys Set to Delist Following Acquisition by Novartis
MT
MorphoSys Inks Delisting Agreement After Takeover by Novartis
MT
Biotech company Morphosys will soon disappear from the stock exchange
RE
MorphoSys to Leave Deutsche Börse’s MDAX, TecDAX Indices
MT
Three newcomers to the MDax - Rational, TUI and Traton move up
RE
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
MT
Novartis data42 AG completed the acquisition of MorphoSys AG from group of shareholders.
CI
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
MT
Dpa-AFX Overview: COMPANIES from 16.05.2024 - 15:15
DP
Novartis: presents results of tender offer for MorphoSysy
CF
Novartis Takeover Bid for MorphoSys Tops Minimum Acceptance Threshold
MT
European Equities Traded in the US as American Depositary Receipts Decline
MT
MorphoSys AG Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Novartis target Morphosys multiplies losses - takeover schedule stands
DP
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading
MT
Morphosys says takeover by Novartis on course after report of drug safety concern
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOR Stock
  4. MOR2 Stock
  5. News MorphoSys AG
  6. Highlights